353 related articles for article (PubMed ID: 33397371)
21. LINC00200 contributes to the chemoresistance to oxaliplatin of gastric cancer cells via regulating E2F1/RAD51 axis.
Lin M; Xu M; Xu Z; Weng Z; Lin B; Lan Y; Liu Q; Lin X; Pan J
Hum Cell; 2021 Jul; 34(4):1163-1173. PubMed ID: 33822325
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Splicing Factor 3b Subunit 1 (SF3B1) Reduced Cell Proliferation, Induced Apoptosis and Resulted in Cell Cycle Arrest by Regulating Homeobox A10 (HOXA10) Splicing in AGS and MKN28 Human Gastric Cancer Cells.
Zhang Y; Yuan Z; Jiang Y; Shen R; Gu M; Xu W; Gu X
Med Sci Monit; 2020 Jan; 26():e919460. PubMed ID: 31927557
[TBL] [Abstract][Full Text] [Related]
23. Long non‑coding RNA JPX promotes gastric cancer progression by regulating CXCR6 and autophagy via inhibiting miR‑197.
Han X; Liu Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33215222
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion
Liu Y; Zhang YM; Ma FB; Pan SR; Liu BZ
World J Gastroenterol; 2019 Jun; 25(22):2763-2775. PubMed ID: 31235999
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/β-catenin pathway.
Kang Y; Zhang S; Cao W; Wan D; Sun L
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426817
[TBL] [Abstract][Full Text] [Related]
26. LncRNA NEAT1 knockdown attenuates autophagy to elevate 5-FU sensitivity in colorectal cancer via targeting miR-34a.
Liu F; Ai FY; Zhang DC; Tian L; Yang ZY; Liu SJ
Cancer Med; 2020 Feb; 9(3):1079-1091. PubMed ID: 31802650
[TBL] [Abstract][Full Text] [Related]
27. Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer.
Zhu L; Zhu Y; Han S; Chen M; Song P; Dai D; Xu W; Jiang T; Feng L; Shin VY; Wang X; Jin H
Cell Death Dis; 2019 May; 10(6):383. PubMed ID: 31097692
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways.
Jiang H; Wang Y; Ai M; Wang H; Duan Z; Wang H; Zhao L; Yu J; Ding Y; Wang S
Cell Death Dis; 2017 Jun; 8(6):e2862. PubMed ID: 28594403
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
[TBL] [Abstract][Full Text] [Related]
30. The long non-coding RNA CRNDE competed endogenously with miR-205 to promote proliferation and metastasis of melanoma cells by targeting CCL18.
Xu L; Zhang Y; Zhao Z; Chen Z; Wang Z; Xu S; Zhang X; Liu T; Yu S
Cell Cycle; 2018; 17(18):2296-2308. PubMed ID: 30257602
[TBL] [Abstract][Full Text] [Related]
31. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
[TBL] [Abstract][Full Text] [Related]
32. Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer.
Xu S; Wang P; Zhang J; Wu H; Sui S; Zhang J; Wang Q; Qiao K; Yang W; Xu H; Pang D
Mol Cancer; 2019 Apr; 18(1):89. PubMed ID: 30999914
[TBL] [Abstract][Full Text] [Related]
33. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
[No Abstract] [Full Text] [Related]
34. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
[TBL] [Abstract][Full Text] [Related]
35. Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer.
Park WC; Kim HR; Kang DB; Ryu JS; Choi KH; Lee GO; Yun KJ; Kim KY; Park R; Yoon KH; Cho JH; Lee YJ; Chae SC; Park MC; Park DS
BMC Cancer; 2016 Jun; 16():358. PubMed ID: 27282379
[TBL] [Abstract][Full Text] [Related]
36. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
Wan L; Yu W; Shen E; Sun W; Liu Y; Kong J; Wu Y; Han F; Zhang L; Yu T; Zhou Y; Xie S; Xu E; Zhang H; Lai M
Gut; 2019 Jan; 68(1):118-129. PubMed ID: 29114070
[TBL] [Abstract][Full Text] [Related]
37. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
[TBL] [Abstract][Full Text] [Related]
38. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF.
Wang J; Su L; Chen X; Li P; Cai Q; Yu B; Liu B; Wu W; Zhu Z
Biomed Pharmacother; 2014 Jun; 68(5):557-64. PubMed ID: 24857172
[TBL] [Abstract][Full Text] [Related]
39. MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer.
He W; Liang B; Wang C; Li S; Zhao Y; Huang Q; Liu Z; Yao Z; Wu Q; Liao W; Zhang S; Liu Y; Xiang Y; Liu J; Shi M
Oncogene; 2019 Jun; 38(23):4637-4654. PubMed ID: 30742067
[TBL] [Abstract][Full Text] [Related]
40. CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5-FU-induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway.
Sun Y; Jiang Y; Huang J; Chen H; Liao Y; Yang Z
Cancer Med; 2017 Oct; 6(10):2331-2346. PubMed ID: 28857517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
